Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Puerariae Lobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain–gut barriers
Runzhi Chen, Peng Wu, Zheng Cai, et al.
The Journal of Nutritional Biochemistry (2018) Vol. 65, pp. 101-114
Closed Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Fecal Microbiota Transplantation in Neurological Disorders
Karuna E.W. Vendrik, Rogier E. Ooijevaar, Pieter R. C. de Jong, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 329
Oscillospira - a candidate for the next-generation probiotics
Jingpeng Yang, Yanan Li, Zhiqiang Wen, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 313
Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota
Runzhi Chen, Ying Xu, Peng Wu, et al.
Pharmacological Research (2019) Vol. 148, pp. 104403-104403
Closed Access | Times Cited: 307
Dysbiosis of Gut Microbiota and Short‐Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes
Chuhong Tan, Qiheng Wu, Huidi Wang, et al.
Journal of Parenteral and Enteral Nutrition (2020) Vol. 45, Iss. 3, pp. 518-529
Open Access | Times Cited: 166
Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke
Ting Zhu, Lei Wang, Yicheng Feng, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 110
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway
Ting Xia, Wen He, Zhen‐Ye Luo, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132256-132256
Closed Access | Times Cited: 18
Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice
Hongna Mu, Qi Zhou, Ruiyue Yang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 139
Dietary ferulic acid and vanillic acid on inflammation, gut barrier function and growth performance in lipopolysaccharide-challenged piglets
Ruizhi Hu, Shusong Wu, Baizhen Li, et al.
Animal nutrition (2021) Vol. 8, pp. 144-152
Open Access | Times Cited: 89
Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain
Haoming Xu, Hong‐Li Huang, Youlian Zhou, et al.
Gastroenterology Research and Practice (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 77
Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets
Xue Gong, Qianyun Cai, Xu Liu, et al.
Microbial Pathogenesis (2021) Vol. 155, pp. 104899-104899
Closed Access | Times Cited: 65
Ganoderic acid A from Ganoderma lucidum protects against alcoholic liver injury through ameliorating the lipid metabolism and modulating the intestinal microbial composition
Xu‐Cong Lv, Qi Wu, Ying-Jia Cao, et al.
Food & Function (2022) Vol. 13, Iss. 10, pp. 5820-5837
Closed Access | Times Cited: 63
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
Ruiling Xu, Yuxuan Zhang, Shurui Chen, et al.
Critical Reviews in Microbiology (2022) Vol. 49, Iss. 2, pp. 151-176
Open Access | Times Cited: 56
Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies
Xuelun Zou, Lei‐Yun Wang, Linxiao Xiao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Yaoyuan Zhang, Zhu Xiao, Xinyuan Yu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 42
Gut microbiota-derived melatonin from Puerariae Lobatae Radix-resistant starch supplementation attenuates ischemic stroke injury via a positive microbial co-occurrence pattern
Zhuoshi Lian, Ying Xu, Chan Wang, et al.
Pharmacological Research (2023) Vol. 190, pp. 106714-106714
Open Access | Times Cited: 36
Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats
Haigang Li, Yi Zhou, Luanfeng Liao, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 33
Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke
Xiaoqiang Xie, Lei Wang, Shan‐Shan Dong, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 3, pp. 519-528
Open Access | Times Cited: 33
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 31
Berberine modulates gut microbiota to attenuate cerebral ferroptosis induced by ischemia-reperfusion in mice
Xinyu Wang, Jiamin Zhang, Sisi Wang, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175782-175782
Open Access | Times Cited: 24
Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review
Yushan Ren, Gang Chen, Ying Hong, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 185-200
Open Access | Times Cited: 1
The impact of gut microbiota on the occurrence, treatment, and prognosis of ischemic stroke
Liying Chen, Xi Wang, Shiqi Wang, et al.
Neurobiology of Disease (2025), pp. 106836-106836
Open Access | Times Cited: 1
Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment
Magdalena Koszewicz, Joanna Jaroch, Anna Brzecka, et al.
Pharmacological Research (2020) Vol. 164, pp. 105277-105277
Closed Access | Times Cited: 59
Intestinal Flora: A Pivotal Role in Investigation of Traditional Chinese Medicine
Xiao Li, Dan Wu, Jingjie Niu, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 02, pp. 237-268
Closed Access | Times Cited: 56
Notoginsenoside R1 activates the NAMPT-NAD+-SIRT1 cascade to promote postischemic angiogenesis by modulating Notch signaling
Ting Zhu, Weijie Xie, Lei Wang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111693-111693
Open Access | Times Cited: 56
Angong Niuhuang Pill ameliorates cerebral ischemia/reperfusion injury in mice partly by restoring gut microbiota dysbiosis
Han Zhang, Xianrui Hui, Yule Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top